Most patients recover with corticosteroid therapy. A standardized approach to dosing starting at 0.75 mg/kg and weaning over 24 weeks has been shown to reduce total corticosteroid exposure without affecting outcome. About two thirds of patients recover with corticosteroid therapy: the usual corticosteroid administered is prednisolone in Europe and prednisone in the US; these differ by only one functional group and have the same clinical effect. The corticosteroid is initially administered in high dosage, typically 50 mg per day tapering down to zero over a six-month to one-year period. If the corticosteroid treatment is halted too quickly the disease may return.
Cryptogenic organizing pneumonia
Acute eosinophilic pneumonia
Atypical pneumonia
Allergic bronchopulmonary aspergillosis
Chronic pulmonary aspergillosis
Eosinophilic pneumonia
Parasitic pneumonia
Fungal pneumonia